|1.||Sakagami, Hiroshi: 3 articles (01/2013 - 09/2006)|
|2.||Osaki, T: 3 articles (09/2001 - 08/2001)|
|3.||Yamamoto, T: 3 articles (09/2001 - 08/2001)|
|4.||Haga, Takahiro: 2 articles (01/2015 - 09/2014)|
|5.||Aiba, Setsuya: 2 articles (01/2015 - 09/2014)|
|6.||Fujimura, Taku: 2 articles (01/2015 - 09/2014)|
|7.||Fujiwara, Kunio: 2 articles (01/2011 - 01/2011)|
|8.||Kikuchi, Hirotaka: 2 articles (07/2008 - 09/2006)|
|9.||Ishihara, Mariko: 2 articles (07/2008 - 09/2006)|
|10.||Kunii, Shiro: 2 articles (07/2008 - 09/2006)|
07/01/2003 - "This study was preliminary clinical practice of tumor imaging and radioimmunoguided surgery (RGS) using (99m)Tc-PPM (peplomycin) as a tumor tracer. "
12/01/1994 - "Patients with superficial transitional cell cancer of the urinary bladder were entered into a randomized trial to compare the effects of immediate and short-term postoperative instillation of peplomycin sulfate with simple irrigation. "
10/20/1983 - "[Therapeutic effect of peplomycin in cervical cancer, with special reference to pathohistological studies]."
07/01/2008 - "Although the antiproliferative activity of peplomycin declined with increasing cell density, peplomycin showed tumor-specific cytotoxicity at any cell density. "
06/01/1996 - "We diagnosed the tumor inoperable radically and administered 10 mg peplomycin once a week for 10 weeks intravenously. "
|2.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/20/1987 - "[Pharmacokinetic study of peplomycin given by continuous infusion from the vagina or cervix in squamous cell carcinoma of the uterine cervix]."
01/01/1983 - "A phase II trial has been performed in squamous cell carcinoma of the lung using peplomycin. "
01/01/1983 - "A phase II trial of peplomycin in squamous cell carcinoma of the lung."
01/01/2015 - "Immunomodulatory effects of peplomycin on immunosuppressive and cytotoxic cells in the lesional skin of cutaneous squamous cell carcinoma."
09/01/2014 - "Successful Treatment of Two Cases of Squamous Cell Carcinoma on the Ear with Intra-Arterial Administration of Peplomycin through a Superficial Temporal Artery."
|3.||Neoplasm Metastasis (Metastasis)
07/01/1991 - "A new dosage form (PEP-CH) of peplomycin was tested for therapeutic efficacy against lymph node metastasis in mice. "
03/01/1988 - "Enhanced therapeutic efficacy on lymph node metastasis by the use of peplomycin adsorbed on small activated carbon particles."
09/01/2001 - "The rate of metastasis in the cervical lymph node was significantly decreased in the groups treated with the cisplatin or peplomycin on day 7 after implantation. "
04/01/1999 - "Interestingly, continuous subcutaneous infusion of peplomycin for the lymph node metastasis significantly improved the warty lesions of porokeratosis. "
10/01/1989 - "Postoperative chemotherapy was performed with CDDP, VP-16 and peplomycin, and postoperative course was uneventful with no distant metastasis or local recurrence. "
06/01/1988 - "[Experimental study on the effects of peplomycin on tongue carcinoma induced by 4-nitroquinoline 1-oxide (4 NQO) in rats. "
01/01/1988 - "[Experimental study on the effects of peplomycin on tongue carcinoma induced by 4-nitroquinoline 1-oxide (4NQO) in rats. "
07/01/1987 - "Phase II study of peplomycin in advanced breast carcinoma."
12/01/2004 - "To investigate the mechanism of peplomycin (PEP)-induced apoptosis in liver carcinoma cell line (Bel-7402). "
12/01/2004 - "Peplomycin induces G1-phase specific apoptosis in liver carcinoma cell line Bel-7402 involving G2-phase arrest."
|5.||Urinary Bladder Neoplasms (Bladder Cancer)
01/01/1991 - "Clinical efficacy of HPC-PEP and tissue concentration of peplomycin (PEP) were studied in 12 patients with bladder tumor. "
07/01/1993 - "Hyperthermic intravesical peplomycin perfusion treatment for bladder cancer."
01/01/1989 - "A new peplomycin (PEP) preparation was employed as an emulsion form in hydroxypropylcellulosum (HPC), which is familiar to have a liniment effect with a strong affinity to mucosa of the organ, in the management of 6 patients with bladder tumors. "
09/01/1985 - "Hyperthermic intravesical perfusion therapy using peplomycin (40 micrograms/ml) in distilled water at 43 degrees C as a perfusate was performed for 2 to 3 hours in 18 patients with superficial bladder tumors and 2 with deep bladder tumors. "
09/01/1985 - "[Hyperthermic perfusion therapy using peplomycin for bladder cancer]."
|1.||Combination Drug Therapy (Combination Chemotherapy)
|2.||Drug Therapy (Chemotherapy)